# SCGB3A2

## Overview
SCGB3A2 is a gene that encodes the protein secretoglobin family 3A member 2, also known as uteroglobin-related protein 1 (UGRP1). This protein is a member of the secretoglobin family, characterized by its small size and secreted nature. SCGB3A2 is primarily expressed in the respiratory system, particularly in the airway epithelium, where it plays a crucial role in maintaining lung homeostasis through its anti-inflammatory and immunomodulatory activities. The protein is involved in tissue repair, protection against oxidative stress, and lung development, acting as a growth factor that influences gene expression related to lung morphogenesis (Reynolds2002Secretoglobins; Kurotani2008Role). SCGB3A2 also interacts with various proteins, contributing to biological processes such as fetal lung development and cancer biology, where it has potential therapeutic implications (Kurotani2008Role; Yokoyama2021Secretoglobin). Alterations in SCGB3A2 expression are associated with several respiratory diseases, including pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), and bronchopulmonary dysplasia (BPD), highlighting its clinical significance (Cai2015Secretoglobin; Reynolds2002Secretoglobins).

## Structure
SCGB3A2, also known as uteroglobin-related protein 1 (UGRP1), is a member of the secretoglobin family characterized by its small size and secreted nature. The primary structure of SCGB3A2 consists of a specific sequence of amino acids, with the human and mouse proteins being 93 and 91 amino acids in length, respectively (Reynolds2002Secretoglobins). The protein is leucine-rich and hydrophobic, with a significant proportion of nonpolar residues (Reynolds2002Secretoglobins).

The secondary structure of SCGB3A2 is predicted to include four alpha-helical structures, a common feature within the secretoglobin family (Reynolds2002Secretoglobins; Jackson2011Update). These helices contribute to the protein's ability to form antiparallel dimers, which are stabilized by disulfide bridges and non-covalent interactions (Jackson2011Update).

In terms of quaternary structure, SCGB3A2 forms dimers, which are resistant to proteases, heat, and pH changes (Jackson2011Update). The dimerization creates an internal hydrophobic cavity that may serve as a binding site for small hydrophobic ligands, such as steroid hormones (Jackson2011Update). The protein's structure and dimerization are crucial for its function in binding and potentially modulating the activity of these ligands.

## Function
SCGB3A2, also known as secretoglobin family 3A member 2, is a protein primarily involved in the respiratory system, where it plays a significant role in maintaining lung homeostasis. It is expressed in the airway epithelium, particularly in Clara cells, and is involved in anti-inflammatory and immunomodulatory activities, contributing to tissue repair and protection against oxidative stress (Reynolds2002Secretoglobins). SCGB3A2 is expressed throughout the conducting airway epithelium in neonatal human lungs, with higher mRNA levels in large cartilaginous airways compared to midlevel bronchi and bronchioles (Reynolds2002Secretoglobins).

In the distal regions of the airways, SCGB3A2+ cells are found in patches of airway epithelium interspersed with alveoli, indicating their specific localization and potential role in alveolar regeneration (Basil2022Human). These cells can give rise to SFTPC+ organoids ex vivo, suggesting a role in alveolar regeneration (Basil2022Human). SCGB3A2 also plays a role in lung development, promoting cell proliferation and influencing gene expression related to lung morphogenesis (Kurotani2008Role). It acts as a growth factor, enhancing the expression of genes associated with lung maturity, such as surfactant proteins, and promoting lung development and maturation in vivo (Kurotani2008Role).

## Clinical Significance
Alterations in the expression of the SCGB3A2 gene have been associated with several respiratory diseases. In pulmonary fibrosis, SCGB3A2 exhibits anti-fibrotic activity. Mice lacking the SCGB3A2 gene show more severe pulmonary fibrosis when exposed to bleomycin, indicating that SCGB3A2 plays a protective role against fibrosis by suppressing TGFβ signaling, which reduces collagen gene expression and fibrosis development (Cai2015Secretoglobin). Transgenic mice overexpressing SCGB3A2 experience a faster resolution of fibrosis, suggesting its potential as a therapeutic agent (Cai2015Transgenicallyexpressed).

SCGB3A2 is also implicated in chronic obstructive pulmonary disease (COPD). It inhibits acrolein-induced apoptosis in lung fibroblast cells by decreasing p53 phosphorylation, which is a critical event in COPD pathogenesis (Kurotani2015SCGB3A2). Additionally, SCGB3A2 serves as a marker for pulmonary carcinomas, although the mechanism of its enhanced expression in carcinomas is not fully understood (Cai2015Secretoglobin).

In bronchopulmonary dysplasia (BPD), altered expression of SCGB3A2 is observed, with reduced levels in the upper airway epithelium of affected neonates, suggesting a role in the disease's pathologic features (Reynolds2002Secretoglobins).

## Interactions
SCGB3A2 interacts with various proteins and plays a significant role in different biological processes. In fetal lung development, SCGB3A2 interacts with a specific receptor or receptor-like molecule on mesenchymal cells, distinct from the macrophage scavenger receptor MARCO, which is not expressed in fetal lung cells. This interaction is crucial for inducing cell proliferation in both epithelial and mesenchymal cells, as evidenced by increased expression of proliferation markers (Kurotani2008Role).

In cancer biology, SCGB3A2 interacts with syndecan-1 (SDC1) and its component heparan sulfate (HS) on the cell surface. This interaction is essential for the growth inhibition of certain epithelial-derived cancer cells, such as non-small cell lung cancers and colorectal cancers, when combined with lipopolysaccharide (LPS). The interaction between SCGB3A2 and the HS moiety of SDC1 is crucial for inducing pyroptosis, a form of programmed cell death, through the activation of the non-canonical inflammasome pathway involving caspase-4 (CASP4) (Yokoyama2021Secretoglobin). These interactions highlight SCGB3A2's potential as a therapeutic agent in cancer treatment, particularly in cancers expressing SDC1 and CASP4 (Yokoyama2021Secretoglobin).


## References


[1. (Yokoyama2021Secretoglobin) Shigetoshi Yokoyama, Shun Nakayama, Lei Xu, Aprile L. Pilon, and Shioko Kimura. Secretoglobin 3a2 eliminates human cancer cells through pyroptosis. Cell Death Discovery, January 2021. URL: http://dx.doi.org/10.1038/s41420-020-00385-w, doi:10.1038/s41420-020-00385-w. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-020-00385-w)

[2. (Cai2015Transgenicallyexpressed) Yan Cai, Mitsuhiro Yoneda, Takeshi Tomita, Reiko Kurotani, Minoru Okamoto, Taketomo Kido, Hiroyuki Abe, Wayne Mitzner, Arjun Guha, and Shioko Kimura. Transgenically-expressed secretoglobin 3a2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice. BMC Pulmonary Medicine, July 2015. URL: http://dx.doi.org/10.1186/s12890-015-0065-4, doi:10.1186/s12890-015-0065-4. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12890-015-0065-4)

[3. (Kurotani2008Role) Reiko Kurotani, Takeshi Tomita, Qian Yang, Bradley A. Carlson, Chi Chen, and Shioko Kimura. Role of secretoglobin 3a2 in lung development. American Journal of Respiratory and Critical Care Medicine, 178(4):389–398, August 2008. URL: http://dx.doi.org/10.1164/rccm.200707-1104oc, doi:10.1164/rccm.200707-1104oc. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1164/rccm.200707-1104oc)

[4. (Jackson2011Update) Brian C Jackson, David C Thompson, Mathew W Wright, Monica McAndrews, Alfred Bernard, Daniel W Nebert, and Vasilis Vasiliou. Update of the human secretoglobin (scgb) gene superfamily and an example of “evolutionary bloom” of androgen-binding protein genes within the mouse scgb gene superfamily. Human Genomics, 5(6):691, 2011. URL: http://dx.doi.org/10.1186/1479-7364-5-6-691, doi:10.1186/1479-7364-5-6-691. This article has 72 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-5-6-691)

[5. (Reynolds2002Secretoglobins) Susan D. Reynolds, Paul R. Reynolds, Gloria S. Pryhuber, Jonathan D. Finder, and Barry R. Stripp. Secretoglobins scgb3a1 and scgb3a2 define secretory cell subsets in mouse and human airways. American Journal of Respiratory and Critical Care Medicine, 166(11):1498–1509, December 2002. URL: http://dx.doi.org/10.1164/rccm.200204-285oc, doi:10.1164/rccm.200204-285oc. This article has 140 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1164/rccm.200204-285oc)

[6. (Kurotani2015SCGB3A2) Reiko Kurotani, Reika Shima, Yuki Miyano, Satoshi Sakahara, Yoshie Matsumoto, Yoko Shibata, Hiroyuki Abe, and Shioko Kimura. Scgb3a2 inhibits acrolein-induced apoptosis through decreased p53 phosphorylation. ACTA HISTOCHEMICA ET CYTOCHEMICA, 48(2):61–68, 2015. URL: http://dx.doi.org/10.1267/ahc.14065, doi:10.1267/ahc.14065. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1267/ahc.14065)

[7. (Basil2022Human) Maria C. Basil, Fabian L. Cardenas-Diaz, Jaymin J. Kathiriya, Michael P. Morley, Justine Carl, Alexis N. Brumwell, Jeremy Katzen, Katherine J. Slovik, Apoorva Babu, Su Zhou, Madison M. Kremp, Katherine B. McCauley, Shanru Li, Joseph D. Planer, Shah S. Hussain, Xiaoming Liu, Rebecca Windmueller, Yun Ying, Kathleen M. Stewart, Michelle Oyster, Jason D. Christie, Joshua M. Diamond, John F. Engelhardt, Edward Cantu, Steven M. Rowe, Darrell N. Kotton, Harold A. Chapman, and Edward E. Morrisey. Human distal airways contain a multipotent secretory cell that can regenerate alveoli. Nature, 604(7904):120–126, March 2022. URL: http://dx.doi.org/10.1038/s41586-022-04552-0, doi:10.1038/s41586-022-04552-0. This article has 169 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41586-022-04552-0)

[8. (Cai2015Secretoglobin) Yan Cai and Shioko Kimura. Secretoglobin 3a2 exhibits anti-fibrotic activity in bleomycin-induced pulmonary fibrosis model mice. PLOS ONE, 10(11):e0142497, November 2015. URL: http://dx.doi.org/10.1371/journal.pone.0142497, doi:10.1371/journal.pone.0142497. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0142497)